Switzerland has “bet on the right horses” with the messenger RNA (mRNA) vaccines from Moderna and Pfizer/Biontech, which are also effective against new variants, according to Steve Pascolo, an immunologist at Zurich University Hospital.
“If 50% of the population receive two doses of vaccine, Switzerland can expect a summer like in Israel,” he told SonntagsBlick newspaper.
Israel has vaccinated over three-quarters of its adult population in just over three months. Infection rates have plummeted, allowing the country to reopen its economy. Israelis are happily resuming routines that were disrupted over 12 months ago.
Sair Reddy, a researcher at the federal technology institute ETH Zurich, agrees with Pascolo: “This is a realistic prognosis. The mRNA vaccines are clearly more effective against mutations. It will be a very good summer.”
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
The Swiss vaccination campaign is accelerating nationwide (around 51,000 jabs a day), despite hiccups and delays with deliveries. Some 2.6 million Covid-19 doses were administered between late December and April 28, by which time almost 11% of the population had been fully vaccinated.
The Swiss government has ordered nearly 36 million vaccine doses from five companies. Health regulator Swissmedic has given the green light to three Covid-19 vaccines: from Pfizer/BioNTech, Moderna and Johnson & Johnson. But only the first two are being administered.
As part of initial easing, restaurants and bars have resumed outdoor services while theatres, cinemas and concert halls can re-open under strict safety conditions.
On April 21, the government outlined a detailed plan for a phase-out from the Covid restrictions. The gradual lifting of the curbs is linked to the response to an anti-Covid vaccination programme.
Swisscom receives greenlight for acquisition of Vodafone Italia
This content was published on
The takeover of Vodafone Italia by Swisscom is nearing completion. All relevant authorities have now approved the €8 billion (CHF7.45 billion) deal.
Novo Nordisk stock market plunge drags down Swiss device maker Ypsomed
This content was published on
The Danish pharmaceutical giant, Novo Nordisk, faced setbacks on Friday that weighed on the share price of Swiss injection device manufacturer Ypsomed.
Swiss press react to EU deal with mix of euphoria and scepticism
This content was published on
Swiss media reaction to the agreement between Switzerland and the EU varies widely. Some are celebrating, while others worry about what is to come.
Swiss Solidarity donations to tackle child abuse top CHF4 million
This content was published on
Swiss Solidarity, the humanitarian arm of the Swiss Broadcasting Corporation (SBC), has raised over CHF4 million ($4.3 million) to tackle child abuse.
EU Commission president says Swiss-EU deal is ‘historic’ agreement
This content was published on
At a joint media conference with Swiss President Viola Amherd in Bern, European Commission President Ursula von der Leyen spoke of a "day of joy".
Switzerland and EU reach deal on future bilateral relations
This content was published on
Switzerland and the European Union have announced a political agreement to update their trading relationship after almost a decade of difficult talks.
Lonza to double production of Covid-19 vaccine at Swiss plant
This content was published on
The Swiss firm will add three more production lines to its plant as part of a larger effort to boost Moderna’s global supply of vaccine doses.
Covid-19: Government prepares to greenlight mass events
This content was published on
The Swiss government wants to allow sports and culture events with up to 3,000 spectators from July if the epidemiological situation remains stable.
Plans outlined for gradual phase-out of anti-Covid restrictions
This content was published on
The government has presented a detailed timetable for relaxing Covid restrictions in Switzerland over the next few months.
‘Brave but risky’: Swiss papers react to Covid-19 easing plan
This content was published on
The Swiss media have reacted with surprise, relief and concern following yesterday’s government decision to further relax Covid restrictions.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.